Somatic genetic changes accompanying lung tumor development

Genes Chromosomes and Cancer

Volumn 44, Issue 1, 2005, Pages 65-75

  Foster, Nicola A ^a,b   Banerjee, Anindo K ^a   Xian, Jian ^a   Roberts, Ian ^b   Pezzella, Francesco ^c   Coleman, Nicholas ^b   Nicholson, Andrew G ^d   Goldstraw, Peter ^d   George, Jeremy P ^e   Rabbitts, Pamela H ^a,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e MIDDLESEX HOSPITAL   (United Kingdom)

^f Centre for Respiratory Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

AGED; ALLELE; ARTICLE; BRONCHOSCOPY; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CARCINOMA IN SITU; CASE REPORT; CELL POPULATION; CHROMOSOME 3Q; CHROMOSOME 4P; CHROMOSOME 5Q; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE; FOLLOW UP; GENE AMPLIFICATION; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG CARCINOMA; LUNG TUMOR; MICRODISSECTION; MORPHOLOGY; PRECANCER; PRIORITY JOURNAL; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ADULT; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICROSATELLITE REPEATS; MUTATION; NUCLEIC ACID HYBRIDIZATION;

EID: 23044455217     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20223     Document Type: Article

References (38)

1. Auerhach O, Petrick TG, Stout AP, Starsiuger AL, Muehsam GE, Forman JB, Gere JB. 1956. The anatomical approach to the study of smoking and bronchogenic carcinoma. Cancer 9:76-83.
2. Auerhach O, Stout AP, Hammond KC, Garfinkel L. 1961. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 265:255-267.
3. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, Testa JR. 1997. Comparative genomic hybridization analysis detects frequent, often high-level, over-representation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 5:2116-2120.
4. Banerjee AK, Rabbitts PH, George J. 2004 Preinvasive bronchial lesions, surveillance or intervention? Chest 125:95s-96s.
5. Barrett MT, Sanehez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ. 1999. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22:106-109.
6. Bota S, Autiac JB, Paris C, Metayer J, Sesboue R, Nouvet G, Thiberville L. 2001. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 164:1688-1693.
7. Boyle JO, Lonardo F, Chang JH, Klimstra D, Ruseh V, Dmitrovsky E. 2001. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Clin Cancer Res 7:259-266.
8. Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. 1995 Sequential molecular genetic changes in lung cancer development. Oncogenc 11:2591-2598.
9. Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. 1996. Clonal evolution of lung tumours. Cancer Res 56:1609-1614.
10. Cooper CA, Bubb VJ, Smithson X, Carter RL, Gledhilt S, Lamb D, Wyllie AH, Carey FA. 1996. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of APC mutation. J Pathol 80:33-37.
11. Franklin WA, Gazdar AF, Haney J, Wistuba H. La Rosa FG, Kennedy T, Ritchey DM, Miller YE. 1997. Widely dispersed p.53 mutation in respiratory epithelium. A novel mechanism for field careinogenesis. J Clin Invest 100:2133-2137.
12. Heselmeyer K, Schroek K, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. 1996. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93:479-484.
13. Hirsch KR, Franklin WA, Gazdar AF, Bunn PA Jr. 2001. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7:5-22.
14. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, Gazdar AE. 1995. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558-563.
15. Kallioniemi A, Kallionicmi OP, Sudar D, Rutovitz D, Gray JW, Waldman K, Pinkel D. 1992. Comparative genomic hybridisation for molecular cytogenetic analysis of solid tumours. Science 258: 818-821.
16. Lam S, MacAulay C. leRiche JC, Dyachkova Y, Coldinan A, Guillaud M, Hawk E, Christen MO, Gazdar AF. 2000. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 89:2468-2473.
17. Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM, Gray JW. 2002. Gcnomic copy number analysis of non-small cell lung cancer using array comparative gcuomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res 62:3636-3640.
18. Massion PP, Taflan PM, Jamshcdur Rahman SM, Yildiz P, Shyr Y, Edgerton MK, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. 2003. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63:7113-7121.
19. Pasic A, Vonk-Noordegraaf A, Risse EK, Postmus PK, Sutedja TG. 2003. Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mneosa in high risk patients. Lung Cancer 41:295-301.
20. Ponticiello A, Barra E, Giani L, Bocchino M, Sanduzzi A. 2000. p53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study. Eur Respir J 15: 547-552.
21. Saccomanno G, Archer VE, Auerbach O, Saundcrs RP, Brennan LM. 1974. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33:256-270.
22. Sato M, Mori Y, Sakurada A, Fukushige S, Ishikawa Y, Tsuchiya E, Saito Y, Nukiwa T, Fujimura S. Horii A. 1998a. Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer. Genes Chromosomes Cancer 22:1-8.
23. Sato M, Mori Y, Sakurada A, Fujimura S, Horii A. 1998b. The 11-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Get 103:96-101.
24. Satoh Y, Ishikawa Y, Nakagawa K, Hirano T, Tsuchiya K. 1997. A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein over-expression in the bronchi of ex-chromate workers. Br J Cancer 75:678-683.
25. Sekido Y, Fong KM, Minna J. 2003. Molecular genetics of lung cancer. Ann Rev Meet 54:73-78.
26. Shahnavaz SA, Bradley G, Regezi J, Thakker N, Gao L, Hogg D, Jordan RC. 2001. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas. Cancer Res 61:2371-2375.
27. Shivapurkar N, Virmani AK, Wistuba H, Milehgrub S, Mackay B, Minna JD, Gazdur AF. 1999. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 5:17-23.
28. Singh B, Stoffel A, Gogineni S, Poltiri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH. 2002. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 161:365-371.
29. Sozzi G, Oggionni M. Alasio L, Conte D, Tavecchio L, Pilotti S, Spinelli P, Calarco G. 2002. Molecular changes track recurrence and progression of bronchial precancerous lesions. Lung Cancer 37:267-270.
30. Stanton SK, Shin SW, Johnson BE, Meyerson M. 2000. Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosomes Cancer 27:323-331.
31. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbitts P. 1992. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989-1997.
32. Takeichi M. 1993. Cadherins in cancer: implications for invasiveness and metastasis. Ctirr Opin Cell Biol 5:806-811.
33. Telenius II, Carter NP, Bebb CE., Nordenskjuöld M, Ponder BAJ, Tunnacliffe A. 1992. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718-725.
34. Thiberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvet G, Palcic B, Lam S. 1995. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 55:5133-5139.
35. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla K. 1999. Histological typing of tumours of lung and pleura. In Sobin LH, editor. World Health Organisation International classification of tumours.3rd ed. New York: Springer-Verlag.
36. Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Knglcs J. Danenberg PV, Yang S, Sidransky D. 2002. Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 62:371-375.
37. Venmans BJ, van Boxem TJ, Smit EF, Postmus PE, Sutedja TG. 2000. Outcome of bronchial carcinoma in situ. Chest 117:1572-1576.
38. Wistuba TI, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AE. 1999. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogcne 18:643-650.